Ventracor (ASX:VCR) Announces European Approval For New Version VentrAssist LVAD

Ventracor (ASX: VCR) announced CE Marking approval for the next version of the VentrAssist(tm) left ventricular assist device (LVAD) which allows it to be marketed and sold in Europe. The US Food & Drug Administration (FDA) approved use of the new version earlier this week. [click link for full article]

More: continued here

Filed under: Cardiovascular on December 20th, 2007